Comment on

• Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.

  Faurschou M, Westman K, Rasmussen N, de Groot K, Flossmann O, Höglund P, Jayne DR; European Vasculitis Study Group. Faurschou M, et al. Arthritis Rheum. 2012 Oct;64(10):3472-7. doi: 10.1002/art.34547. Arthritis Rheum. 2012. PMID: 22614882 Clinical Trial.
• Methotrexate remains a valuable option for remission induction of nonsevere antineutrophil cytoplasmic antibody-associated vasculitis: comment on the article by Faurschou et al.

  Langford CA, Hoffman GS. Langford CA, et al. Arthritis Rheum. 2013 Mar;65(3):843. doi: 10.1002/art.37791. Arthritis Rheum. 2013. PMID: 23203421 No abstract available.